Cargando…
Metabolic Syndrome Resolved within Two Years is Still a Risk Factor for Kidney Cancer
The prevalence of metabolic syndrome (MetS) and kidney cancer is increasing, but studies on the effects of MetS and its components on kidney cancer development have had ambiguous results. Overall, 7,613,865 patients from the Korean National Health Insurance System were analyzed and followed up until...
Autores principales: | Oh, Tae Ryom, Han, Kyung-Do, Choi, Hong Sang, Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Kim, Soo Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780562/ https://www.ncbi.nlm.nih.gov/pubmed/31466366 http://dx.doi.org/10.3390/jcm8091329 |
Ejemplares similares
-
Smoking and risk of incident end-stage kidney disease in general population: A Nationwide Population-based Cohort Study from Korea
por: Choi, Hong Sang, et al.
Publicado: (2019) -
Underweight status and development of end‐stage kidney disease: A nationwide population‐based study
por: Kim, Chang Seong, et al.
Publicado: (2023) -
Weight change and risk of depression in patients with diabetic kidney disease: a nationwide population-based study
por: Choi, Hong Sang, et al.
Publicado: (2023) -
Obesity, Abdominal Obesity and Chronic Kidney Disease in Young Adults: A Nationwide Population-Based Cohort Study
por: Bae, Eun Hui, et al.
Publicado: (2021) -
Chronic Kidney Disease Risk of Isolated Systolic or Diastolic Hypertension in Young Adults: A Nationwide Sample Based‐Cohort Study
por: Bae, Eun Hui, et al.
Publicado: (2021)